Todo DSpace

Listar por tema "brain ischemia"

Mostrando ítems 1-20 de 102

    • 20-year trends of characteristics and outcomes of stroke patients with atrial fibrillation 

      Ntaios G., Sagris D., Gioulekas F., Galanis P., Pardali C., Vemmou A., Koroboki E., Papavasileiou V., Vassilopoulou S., Manios E., Makaritsis K., Spengos K., Mitsikostas D.-D., Milionis H., Vemmos K. (2018)
      Background: The accurate knowledge of secular trends in prevalence, characteristics and outcomes of patients with ischemic stroke and atrial fibrillation allows better projections into the future. Aim: We aimed to report ...

    • Access of stroke patients' to optimal healthcare technology in Greece: Messages to policy makers 

      Siskou O., Korompoki E., Ntaios G., Tsampalas E., Alexopoulou H., Kalliontzakis I., Kouridaki A., Tountopoulou A., Kouzi I., Vasilopoulou S., Milionis H., Evaggelou H., Karagkiozi E., Hatzitolios A.I., Savopoulos C., Myrou A., Manios E., Mavraganis G., Vemmou A., Kaitelidou D., Galanis P., Papastefanatos S., Konstantakopoulou O., Karagkouni I., Vemmos K. (2020)
      The aim of this study was to evaluate accessibility of stroke patients to optimal healthcare technology in Greece. Methods: The study population consisted of 313 first ever stroke patients derived from the 'Stroke Units ...

    • Acute limb ischemia and anticoagulation in patients with history of atrial fibrillation 

      Spanos K., Athanasoulas A., Argyriou C., Vassilopoulos I., Giannoukas A.D. (2016)
      BACKGROUND: Atrial fibrillation (AF) is the commonest source of arterial embolization causing acute limb ischemia (ALI). The aim of this study was to assess the adherence of anticoagulation in AF patients and the treatment ...

    • Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation 

      Tiili P., Leventis I., Kinnunen J., Svedjebäck I., Lehto M., Karagkiozi E., Sagris D., Ntaios G., Putaala J. (2021)
      Background: Non-vitamin K antagonist oral anticoagulants (NOAC) have superior safety and comparable efficacy profile compared to vitamin-K antagonists (VKAs), with more convenient dosing schemes. However, issues with ...

    • Advancements in the Treatment of Cerebrovascular Complications of Cancer 

      Aloizou A.-M., Siokas V., Mentis A.-F.A., Dastamani M., Sokratous M., Xiromerisiou G., Mitsias P.D., Hadjigeorgiou G.M., Dardiotis E. (2020)
      Purpose of review: To present the new guidelines and therapeutic options regarding cerebrovascular complications of cancer, mainly ischemic stroke, cerebral venous thrombosis (CVT), and leptomeningeal carcinomatosis (LMC). ...

    • Age- A nd sex-specific analysis of patients with embolic stroke of undetermined source 

      Ntaios G., Lip G.Y.H., Vemmos K., Koroboki E., Manios E., Vemmou A., Rodríguez-Campello A., Cuadrado-Godia E., Roquer J., Arnao V., Caso V., Paciaroni M., DIez-Tejedor E., Fuentes B., Pérez Lucas J., Arauz A., Ameriso S.F., Pertierra L., Gómez-Schneider M., Hawkes M.A., Bandini F., Chavarria Cano B., Iglesias Mohedano A.M., Garciá Pastor A., Gil-Núñez A., Putaala J., Tatlisumak T., Barboza M.A., Athanasakis G., Gioulekas F., Makaritsis K., Papavasileiou V. (2017)
      Objective: To investigate whether the correlation of age and sex with the risk of recurrence and death seen in patients with previous ischemic stroke is also evident in patients with embolic stroke of undetermined source ...

    • Anticoagulation after Stroke in Patients with Atrial Fibrillation: To Bridge or Not with Low-Molecular-Weight Heparin? 

      Altavilla R., Caso V., Bandini F., Agnelli G., Tsivgoulis G., Yaghi S., Furie K.L., Tadi P., Becattini C., Zedde M., Abdul-Rahim A.H., Lees K.R., Alberti A., Venti M., Acciarresi M., D'Amore C., Giulia Mosconi M., Anna Cimini L., Fusaro J., Bovi P., Carletti M., Rigatelli A., Cappellari M., Putaala J., Tomppo L., Tatlisumak T., Marcheselli S., Pezzini A., Poli L., Padovani A., Masotti L., Vannucchi V., Sohn S.-I., Lorenzini G., Tassi R., Guideri F., Acampa M., Martini G., Ntaios G., Athanasakis G., Makaritsis K., Karagkiozi E., Vadikolias K., Liantinioti C., Chondrogianni M., Mumoli N., Consoli D., Galati F., Sacco S., Carolei A., Tiseo C., Corea F., Ageno W., Bellesini M., Silvestrelli G., Ciccone A., Lanari A., Scoditti U., Denti L., Mancuso M., MacCarrone M., Ulivi L., Orlandi G., Giannini N., Gialdini G., Tassinari T., De Lodovici M.L., Bono G., Rueckert C., Baldi A., D'Anna S., Toni D., Letteri F., Giuntini M., Lotti E.M., Flomin Y., Pieroni A., Kargiotis O., Karapanayiotides T., Monaco S., Baronello M.M., Csiba L., Szabó L., Chiti A., Giorli E., Del Sette M., Imberti D., Zabzuni D., Doronin B., Volodina V., Michel P., Vanacker P., Barlinn K., Pallesen L.-P., Barlinn J., Deleu D., Melikyan G., Ibrahim F., Akhtar N., Gourbali V., Paciaroni M. (2019)
      Background and Purpose-Bridging therapy with low-molecular-weight heparin reportedly leads to a worse outcome for acute cardioembolic stroke patients because of a higher incidence of intracerebral bleeding. However, this ...

    • Antiplatelet Resistance in Ischaemic Stroke Patients 

      Spanos K., Kouvelos G., Matsagkas M., Giannoukas A.D. (2017)
      [No abstract available]

    • Aspirin Versus Clopidogrel for Type 2 Diabetic Patients with First-Ever Noncardioembolic Acute Ischemic Stroke: Ten-Year Survival Data from the Athens Stroke Outcome Project 

      Milionis H., Ntaios G., Papavasileiou V., Spengos K., Manios E., Elisaf M., Vemmos K. (2017)
      Background and objective Diabetes mellitus is associated with an increased risk of stroke and poor outcome following a stroke event. We assessed the impact of discharge treatment with aspirin versus clopidogrel on the ...

    • Assessment of the reporting quality of double-blind RCTs for ischemic stroke based on the CONSORT statement 

      Kodounis M., Liampas I.N., Constantinidis T.S., Siokas V., Mentis A.-F.A., Aloizou A.-M., Xiromerisiou G., Zintzaras E., Hadjigeorgiou G.M., Dardiotis E. (2020)
      Background-Purpose: It is critical that Randomized Controlled Trials(RCTs) present complete and transparent reporting. The present study aims to determine the reporting quality of double-blind RCTs for medicinal interventions ...

    • Association of hypertensive intracerebral hemorrhage with left ventricular hypertrophy on transthoracic echocardiography 

      Pallesen L.-P., Wagner J., Lambrou D., Braun S., Weise M., Prakapenia A., Barlinn J., Siepmann T., Winzer S., Moustafa H., Kitzler H.H., Barlinn K., Reichmann H., Puetz V. (2020)
      Introduction: Arterial hypertension is the most frequent cause for spontaneous intracerebral hemorrhage (sICH) and may also cause left ventricular hypertrophy (LVH). We sought to analyze whether hypertensive sICH etiology ...

    • Associations between change in blood pressure and functional outcome, early events and death: Results from the Efficacy of Nitric Oxide in Stroke trial 

      Sandset E.C., Appleton J.P., Berge E., Christensen H., Gommans J., Krishnan K., Ntaios G., Phillips S., Pocock S., Sprigg N., Woodhouse L.J., Bath P.M. (2019)
      Objectives:High blood pressure (BP) is associated with a poor outcome after acute stroke. Early reduction in BP may be associated with fewer early adverse events and deaths, and improved functional outcome.Methods:Analyses ...

    • ASTRAL, DRAGON and SEDAN scores predict stroke outcome more accurately than physicians 

      Ntaios G., Gioulekas F., Papavasileiou V., Strbian D., Michel P. (2016)
      Background and purpose: ASTRAL, SEDAN and DRAGON scores are three well-validated scores for stroke outcome prediction. Whether these scores predict stroke outcome more accurately compared with physicians interested in ...

    • ASTRAL-R score predicts non-recanalisation after intravenous thrombolysis in acute ischaemic stroke 

      Vanacker, P.; Heldner, M. R.; Seiffge, D.; Mueller, H.; Eskandari, A.; Traenka, C.; Ntaios, G.; Mosimann, P. J.; Sztajzel, R.; Pereira, V. M.; Cras, P.; Engelter, S.; Lyrer, P.; Fischer, U.; Lambrou, D.; Arnold, M.; Michel, P. (2015)
      Intravenous thrombolysis (IVT) as treatment in acute ischaemic strokes may be insufficient to achieve recanalisation in certain patients. Predicting probability of non-recanalisation after IVT may have the potential to ...

    • Atrial fibrillation and cognitive decline: it takes more than an irregular heart beat, to beat the brain 

      Sagris D., Lip G.Y.H. (2021)
      [No abstract available]

    • Cancer-associated stroke: Pathophysiology, detection and management (Review) 

      Dardiotis E., Aloizou A.-M., Markoula S., Siokas V., Tsarouhas K., Tzanakakis G., Libra M., Kyritsis A.P., Brotis A.G., Aschner M., Gozes I., Bogdanos D.P., Spandidos D.A., Mitsias P.D., Tsatsakis A. (2019)
      Numerous types of cancer have been shown to be associated with either ischemic or hemorrhagic stroke. In this review, the epidemiology and pathophysiology of stroke in cancer patients is discussed, while providing vital ...

    • Cardiovascular care of patients with stroke and high risk of stroke: The need for interdisciplinary action: A consensus report from the European Society of Cardiology Cardiovascular Round Table 

      Doehner W., Mazighi M., Hofmann B.M., Lautsch D., Hindricks G., Bohula E.A., Byrne R.A., Camm A.J., Casadei B., Caso V., Cognard C., Diener H.-C., Endres M., Goldstein P., Halliday A., Hopewell J.C., Jovanovic D.R., Kobayashi A., Kostrubiec M., Krajina A., Landmesser U., Markus H.S., Ntaios G., Pezzella F.R., Ribo M., Rosano G.M.C., Rubiera M., Sharma M., Touyz R.M., Widimsky P. (2020)
      Comprehensive stroke care is an interdisciplinary challenge. Close collaboration of cardiologists and stroke physicians is critical to ensure optimum utilisation of short- and long-term care and preventive measures in ...

    • Case Series: Bilateral Homonymous Visual Field Defects Due to Bilateral Ischemic Strokes 

      Papageorgiou E., Anthis N., Stathi T., Tsironi E., Asproudis I. (2018)
      SIGNIFICANCE Bilateral strokes are rare and should be considered when patients present with bilateral visual field loss characterized by patterns consistent with right and left-sided homonymous visual field defects. ...

    • Causes and Risk Factors of Cerebral Ischemic Events in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention: The RENo Study 

      Paciaroni M., Agnelli G., Caso V., Silvestrelli G., Seiffge D.J., Engelter S., De Marchis G.M., Polymeris A., Zedde M.L., Yaghi S., Michel P., Eskandari A., Antonenko K., Sohn S.-I., Cappellari M., Tassinari T., Tassi R., Masotti L., Katsanos A.H., Giannopoulos S., Acciarresi M., Alberti A., Venti M., Mosconi M.G., Vedovati M.C., Pierini P., Giustozzi M., Lotti E.M., Ntaios G., Kargiotis O., Monaco S., Lochner P., Bandini F., Liantinioti C., Palaiodimou L., Abdul-Rahim A.H., Lees K., Mancuso M., Pantoni L., Rosa S., Bertora P., Galliazzo S., Ageno W., Toso E., Angelini F., Chiti A., Orlandi G., Denti L., Flomin Y., Marcheselli S., Mumoli N., Rimoldi A., Verrengia E., Schirinzi E., Del Sette M., Papamichalis P., Komnos A., Popovic N., Zarkov M., Rocco A., Diomedi M., Giorli E., Ciccone A., Grory B.C.M., Furie K.L., Bonetti B., Saia V., Guideri F., Acampa M., Martini G., Grifoni E., Padroni M., Karagkiozi E., Perlepe K., Makaritsis K., Mannino M., MacCarrone M., Ulivi L., Giannini N., Ferrari E., Pezzini A., Doronin B., Volodina V., Baldi A., D'Amore C., Deleu D., Corea F., Putaala J., Santalucia P., Nardi K., Risitano A., Toni D., Tsivgoulis G. (2019)
      Background and Purpose-Despite treatment with oral anticoagulants, patients with nonvalvular atrial fibrillation (AF) may experience ischemic cerebrovascular events. The aims of this case-control study in patients with AF ...

    • Central masked adjudication of stroke diagnosis at trial entry offered no advantage over diagnosis by local clinicians: Secondary analysis and simulation 

      Godolphin P.J., Hepburn T., Sprigg N., Walker L., Berge E., Collins R., Gommans J., Ntaios G., Pocock S., Prasad K., Wardlaw J.M., Bath P.M., Montgomery A.A. (2018)
      Background: Central adjudication of stroke type is commonly implemented in large multicentre clinical trials. We investigated the effect of central adjudication of diagnosis of stroke type at trial entry in the Efficacy ...